Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | P2RX4 | Q99571 | 13/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31067286 | 1.00 | KDM4E (0.55) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 | |
| Hydrogen Sulfide SCHEMBL28845788 | 0.97 | KDM4E (0.53) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 | |
| Formic Acid SCHEMBL8502185 | 0.87 | P2RX4 (0.49) | KDM4EALDH1A1P2RX4SMN1; SMN2GAA | |
| SCHEMBL12841614 | 0.84 | KDM4E (0.47) | KDM4EALDH1A1P2RX4SMN1; SMN2GLA | |
| SCHEMBL12776591 | 0.84 | SMN1; SMN2 (0.59) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 | |
| SCHEMBL15183513 | 0.84 | KDM4E (0.47) | KDM4EALDH1A1P2RX4SMN1; SMN2GLA | |
| SCHEMBL4012288 | 0.83 | KDM4E (0.46) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 | |
| SCHEMBL18637369 | 0.82 | KDM4E (0.54) | KDM4EALDH1A1P2RX4 | |
| SCHEMBL19417365 | 0.82 | KDM4E (0.46) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 | |
| SCHEMBL13445191 | 0.82 | KDM4E (0.46) | KDM4EALDH1A1P2RX4MAOASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113200936-B | 10-methylphenoxazine derivative, zirconium metal organic framework material thereof and preparation method | 南京工业大学 | 2022-10-21 | — | — | CN | claimed |
| CN-113200936-A | 10-methylphenoxazine derivative, zirconium metal organic framework material thereof and preparation method | 南京工业大学 | 2021-08-03 | — | — | CN | claimed |
| US-8012705-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2011-09-06 | — | — | US | claimed |
| US-20110183361-A1 | Nonseparation Assay Methods | BECKMAN COULTER, INC. (US) | 2011-07-28 | — | — | US | claimed |
| US-7351395-B1 | Catalytically saturating polycyclic aromatic hydrocarbons for storage, then dehydrogenation with catalyst to release hydrogen; supplying hydrogen to fuel cells | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2008-04-01 | — | — | US | claimed |
| US-20070261806-A1 | Treatment of Pulp Stocks Using Oxidative Enzymes to Reduce Pitch Deposition | ENZYMATIC DEINKING TECHNOLOGIES, LLC | 2007-11-15 | — | — | US | claimed |
| EP-0707637-B1 | ENHANCEMENT OF LACCASE REACTIONS | NOVOZYMES AS (DK) | 2005-11-02 | — | — | EP | claimed |
| EP-1137391-B1 | METHOD FOR TREATING HAIR | NOVOZYMES AS (DK) | 2004-11-03 | — | — | EP | claimed |
| US-20040049859-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | L'OREAL S.A. (FR) | 2004-03-18 | — | — | US | claimed |
| US-20040025265-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | LANG GERARD (FR) | 2004-02-12 | — | — | US | claimed |
| WO-1997031088-A1 | COATED PEROXIDASE-CONTAINING PREPARATION, AND COMPOSITIONS COMPRISING SUCH A PREPARATION | NOVO NORDISK A/S (DK) | 1997-08-28 | — | — | WO | claimed |
| EP-0763094-A1 | DYE-TRANSFER INHIBITORY PREPARATION, AND DETERGENT COMPOSITION COMPRISING SUCH A PREPARATION | NOVO NORDISK A/S (DK) | 1997-03-19 | — | — | EP | claimed |
| EP-0707637-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1996-04-24 | — | — | EP | claimed |
| WO-1996006930-A1 | COPRINACEAE LACCASES | NOVO NORDISK A/S (DK) | 1996-03-07 | — | — | WO | claimed |
| WO-1995033039-A1 | DYE-TRANSFER INHIBITORY PREPARATION, AND DETERGENT COMPOSITION COMPRISING SUCH A PREPARATION | NOVO NORDISK A/S (DK) | 1995-12-07 | — | — | WO | claimed |
| EP-0679183-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK A/S (DK) | 1995-11-02 | — | — | EP | claimed |
| WO-1995001426-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1995-01-12 | — | — | WO | claimed |
| WO-1994012621-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK (DK) | 1994-06-09 | — | — | WO | claimed |
| US-4616069-A | REACTING THE ALKALI METAL OR ALKALINE EARTH METAL TERMINATED POLYMER WITH TIN COMPOUND AND ORGANIC COMPOUND HAVING AMIDE OR THIOAMIDE LINKAGES | NIPPON ZEON CO., LTD. (JP) | 1986-10-07 | — | — | US | claimed |
| US-4614771-A | POLYMERIZATION WITH AROMATIC VINYL MONOMER AND ALKALINE(OR ALKALINE EARTH) METAL, THEN MINO(OR AMINOTHIO)ALDEHYDES OR KETONES | NIPPON ZEON CO., LTD. (JP) | 1986-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040025265-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | KRT18, LPO, ALDH1A2 | KDM4E 498/4885ALDH1A1 494/4885P2RX4 4155/4885 |
| US-20040049859-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | KRT18, COXFA4, LPO | KDM4E 403/4885ALDH1A1 322/4885P2RX4 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.